TipRanks
Advertisement
Advertisement

LYPHF Stock Latest News

Luye Pharma Delivers Higher H1 Profit Despite Revenue Decline
Company AnnouncementsLuye Pharma Delivers Higher H1 Profit Despite Revenue Decline
1M ago
Luye Pharma Advances HPV mRNA Vaccine LY01620 to Phase II in China
PremiumCompany Announcements
Luye Pharma Advances HPV mRNA Vaccine LY01620 to Phase II in China
2M ago
Luye Pharma Sets Board Meeting to Approve Interim Results and Consider Dividend
PremiumCompany Announcements
Luye Pharma Sets Board Meeting to Approve Interim Results and Consider Dividend
2M ago
Luye Pharma Advances CNS Portfolio With Successful U.S. Bridging Trial for LY03015
PremiumCompany Announcements
Luye Pharma Advances CNS Portfolio With Successful U.S. Bridging Trial for LY03015
2M ago
Luye Pharma Wins Shareholder Backing for All AGM Resolutions and Capital Mandates
PremiumCompany Announcements
Luye Pharma Wins Shareholder Backing for All AGM Resolutions and Capital Mandates
3M ago
Luye Pharma’s Novel CNS Drug LY03015 Delivers Strong Phase 2 Data in Tardive Dyskinesia
PremiumCompany AnnouncementsLuye Pharma’s Novel CNS Drug LY03015 Delivers Strong Phase 2 Data in Tardive Dyskinesia
4M ago
Luye Pharma Halves 2028 Convertible Bond Float With US$89.74 Million Buyback
Premium
Company Announcements
Luye Pharma Halves 2028 Convertible Bond Float With US$89.74 Million Buyback
4M ago
Luye Pharma Raises US$180 Million via Premium-Priced 2031 Convertible Bonds
Premium
Company Announcements
Luye Pharma Raises US$180 Million via Premium-Priced 2031 Convertible Bonds
4M ago
Luye Pharma Wins Vienna MTF Listing Approval for New Bond Issue
PremiumCompany Announcements
Luye Pharma Wins Vienna MTF Listing Approval for New Bond Issue
4M ago
Luye Pharma to Swap 2028 Convertible Debt with New 2031 Issue
PremiumCompany Announcements
Luye Pharma to Swap 2028 Convertible Debt with New 2031 Issue
4M ago
Luye Pharma Plans Bond Buyback and New USD Convertible Issue
PremiumCompany Announcements
Luye Pharma Plans Bond Buyback and New USD Convertible Issue
4M ago
Luye Pharma sets 2026 AGM to renew board, auditor and share issuance mandate
PremiumCompany Announcements
Luye Pharma sets 2026 AGM to renew board, auditor and share issuance mandate
4M ago
Luye Pharma Starts U.S. PK Bridging Trial for Novel CNS Drug LY03015
PremiumCompany AnnouncementsLuye Pharma Starts U.S. PK Bridging Trial for Novel CNS Drug LY03015
6M ago
Luye Pharma Advances Alzheimer’s Psychosis Drug LY03017 Into China Phase II Trial
Premium
Company Announcements
Luye Pharma Advances Alzheimer’s Psychosis Drug LY03017 Into China Phase II Trial
6M ago
Luye Pharma Starts Phase II Trial in China for Next-Generation Schizophrenia Drug LY03020
Premium
Company Announcements
Luye Pharma Starts Phase II Trial in China for Next-Generation Schizophrenia Drug LY03020
6M ago
Luye Pharma Delivers Double-Digit Profit Growth in 2025 but Skips Dividend
PremiumCompany Announcements
Luye Pharma Delivers Double-Digit Profit Growth in 2025 but Skips Dividend
6M ago
Luye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
PremiumCompany Announcements
Luye Pharma Sets March 2026 Board Meeting to Approve 2025 Results
7M ago
Luye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
PremiumCompany Announcements
Luye Pharma Completes RMB1.09 Billion Transfer of 25% Stake in Nanjing Luye to NJ Xinshi
8M ago
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
PremiumCompany Announcements
Luye Pharma Injects RMB285 Million into Nanjing Unit via Structured Deal
8M ago
Luye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
PremiumCompany AnnouncementsLuye Pharma’s Ruoxinlin NDA for Anxiety Disorder Accepted in China, Targeting Major CNS Market Gap
9M ago
Luye Pharma Adds Independent Director Xia Lian to Nomination Committee
Premium
Company Announcements
Luye Pharma Adds Independent Director Xia Lian to Nomination Committee
9M ago
Luye Pharma Outlines Board Line-Up and Committee Structure
Premium
Company Announcements
Luye Pharma Outlines Board Line-Up and Committee Structure
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >